These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11106692)

  • 1. Re: population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
    Ameyaw MM; Thornton N; McLeod HL
    J Natl Cancer Inst; 2000 Dec; 92(23):1947. PubMed ID: 11106692
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
    Baxter SW; Campbell IG
    J Natl Cancer Inst; 2001 Apr; 93(7):557-9. PubMed ID: 11287454
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast cancer racial gap examined: no easy answers to explain disparities in survival.
    Vastag B
    JAMA; 2003 Oct; 290(14):1838-42. PubMed ID: 14532299
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
    Hishida A; Hamajima N; Iwata H; Matsuo K; Hirose K; Emi N; Tajima K
    J Natl Cancer Inst; 2002 Dec; 94(23):1807-8. PubMed ID: 12464653
    [No Abstract]   [Full Text] [Related]  

  • 5. HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites.
    Millikan R; Eaton A; Worley K; Biscocho L; Hodgson E; Huang WY; Geradts J; Iacocca M; Cowan D; Conway K; Dressler L
    Breast Cancer Res Treat; 2003 Jun; 79(3):355-64. PubMed ID: 12846420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
    Chen L; Li CI
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women.
    Trabert B; Malone KE; Daling JR; Doody DR; Bernstein L; Ursin G; Marchbanks PA; Strom BL; Humphrey MC; Ostrander EA
    Breast Cancer Res; 2007; 9(6):R84. PubMed ID: 18067661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen Receptor and ALDH1 Expression Among Internationally Diverse Patient Populations.
    Jiagge E; Jibril AS; Davis M; Murga-Zamalloa C; Kleer CG; Gyan K; Divine G; Hoenerhoff M; Bensenhave J; Awuah B; Oppong J; Adjei E; Salem B; Toy K; Merajver S; Wicha M; Newman L
    J Glob Oncol; 2018 Oct; 4():1-8. PubMed ID: 30307804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites.
    Millikan RC; Heard K; Winkel S; Hill EJ; Heard K; Massa B; Mayes L; Williams P; Holston R; Conway K; Edmiston S; de Cotret AR
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):175-7. PubMed ID: 16434608
    [No Abstract]   [Full Text] [Related]  

  • 10. Polymorphisms of ERBB2 and breast cancer risk: a meta-analysis of 26 studies involving 35,088 subjects.
    Wang H; Liu L; Lang Z; Guo S; Gong H; Guan H; Zhang J; Liu B
    J Surg Oncol; 2013 Nov; 108(6):337-41. PubMed ID: 23900832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of breast cancer in ethnic populations: an aid to gene discovery for the benefit of all.
    Goodison S
    Breast J; 2005; 11(2):89-91. PubMed ID: 15730452
    [No Abstract]   [Full Text] [Related]  

  • 12. Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Is Associated with Indigenous American Ancestry in Latin American Women.
    Marker KM; Zavala VA; Vidaurre T; Lott PC; Vásquez JN; Casavilca-Zambrano S; Calderón M; Abugattas JE; Gómez HL; Fuentes HA; Picoaga RL; Cotrina JM; Neciosup SP; Castañeda CA; Morante Z; Valencia F; Torres J; Echeverry M; Bohórquez ME; Polanco-Echeverry G; Estrada-Florez AP; Serrano-Gómez SJ; Carmona-Valencia JA; Alvarado-Cabrero I; Sanabria-Salas MC; Velez A; Donado J; Song S; Cherry D; Tamayo LI; Huntsman S; Hu D; Ruiz-Cordero R; Balassanian R; Ziv E; Zabaleta J; Carvajal-Carmona L; Fejerman L;
    Cancer Res; 2020 May; 80(9):1893-1901. PubMed ID: 32245796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based case-control study of HER2 genetic polymorphism and breast cancer risk.
    Chan KY; Cheung AN; Yip SP; Ko HH; Lai TW; Khoo US
    J Natl Cancer Inst; 2002 Oct; 94(20):1581-2. PubMed ID: 12381713
    [No Abstract]   [Full Text] [Related]  

  • 14. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women.
    Li Y; Millikan RC; Bell DA; Cui L; Tse CK; Newman B; Conway K
    Breast Cancer Res; 2004; 6(4):R460-73. PubMed ID: 15217514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
    Menendez-Tuckman AT; Raventos-Suarez C
    J Natl Cancer Inst; 1994 Sep; 86(17):1352-3. PubMed ID: 8064896
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
    Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
    JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racially restricted contribution of immunoglobulin Fcγ and Fcγ receptor genotypes to humoral immunity to human epidermal growth factor receptor 2 in breast cancer.
    Pandey JP; Namboodiri AM; Kistner-Griffin E; Iwasaki M; Kasuga Y; Hamada GS; Tsugane S
    Clin Exp Immunol; 2013 Mar; 171(3):273-7. PubMed ID: 23379433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites.
    Millikan RC; Player J; de Cotret AR; Moorman P; Pittman G; Vannappagari V; Tse CK; Keku T
    Breast Cancer Res; 2004; 6(4):R264-74. PubMed ID: 15217492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race/ethnicity and cancer survival: the elusive target of biological differences.
    Kiefe CI
    JAMA; 2002 Apr; 287(16):2138-9. PubMed ID: 11966389
    [No Abstract]   [Full Text] [Related]  

  • 20. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
    Xie D; Shu XO; Deng Z; Wen WQ; Creek KE; Dai Q; Gao YT; Jin F; Zheng W
    J Natl Cancer Inst; 2000 Mar; 92(5):412-7. PubMed ID: 10699071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.